H. Al-Madhagi

Reverse vaccinology approach for the design of a transmission-blocking vaccine by targeting the malaria vector Anopheles

This multi-epitope malaria TBV demonstrated predicted immunogenic potency without evidence of allergenicity or toxicity, suggesting its potential to limit the transmission of multidrug-resistant Plasmodium strains.